In Radiation-Induced Adverse Effects of Cancer Patients Pathadi Ghrita is used as An Adjuvant Therapy
Phase 2
- Conditions
- Health Condition 1: D899- Disorder involving the immune mechanism, unspecifiedHealth Condition 2: C760- Malignant neoplasm of head, face and neck
- Registration Number
- CTRI/2021/04/033125
- Lead Sponsor
- KLE Deemed to be UNIVERSITY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Consented patients of Cervical and Head and Neck post operative setting
2 Age 20 to 70 years
Eastern Cooperative Oncology Group performance scale ECOG less than 2
3 Acceptable Baseline Haematological and biochemical parameters
Hb more than 8mg per dl WBC more than 4 billion
Platelet 150 billion Urea less than 40mg per dl
Creatinine less than 1.5mg per dl Total bilirubin less than 1mg per dl SGOT and SGPT less than 50 IU per ml
Exclusion Criteria
1 Uncontrolled Diabetic and Hypertensive patients
2 K/C/O of Hyperlipidemia Thyroid
3 AnyMajor Illness
4 Secondary Cancer patient
5 Recurrent cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method